Cargando…
Histomorphometric Analysis of 38 Giant Cell Tumors of Bone after Recurrence as Compared to Changes Following Denosumab Treatment
SIMPLE SUMMARY: Giant cell tumor of bone (GCTB) is an osteolytic tumor driven by an H3F3A-mutated mononuclear stromal cell with an accumulation of osteoclastic giant cells. Anti-RANKL antibody therapy with denosumab leads to morphological changes, and sarcomas have been described in association with...
Autores principales: | Arndt, Sophia, Hartmann, Wolfgang, Rókusz, András, Leinauer, Benedikt, von Baer, Alexandra, Schultheiss, Markus, Pablik, Jessica, Fritzsche, Hagen, Mogler, Carolin, Antal, Imre, Baumhoer, Daniel, Mellert, Kevin, Möller, Peter, Szendrői, Miklós, Jundt, Gernot, Barth, Thomas F. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486357/ https://www.ncbi.nlm.nih.gov/pubmed/37686526 http://dx.doi.org/10.3390/cancers15174249 |
Ejemplares similares
-
The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases
por: Antal, Imre, et al.
Publicado: (2022) -
Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine
por: Szendrői, Miklós, et al.
Publicado: (2017) -
Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation
por: Hasenfratz, Marc, et al.
Publicado: (2021) -
Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway
por: Lübbehüsen, Christoph, et al.
Publicado: (2019) -
Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma
por: Balogh, Zsófia, et al.
Publicado: (2011)